116 related articles for article (PubMed ID: 8558793)
41. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
42. [Radionuclide diagnosis and therapy of skeletal metastases of prostatic cancer].
Schümichen C
Radiologe; 1984 Jan; 24(1):13-8. PubMed ID: 6200897
[TBL] [Abstract][Full Text] [Related]
43. The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer.
Aoki Y; Nakayama M; Nomura K; Tomita Y; Nakajima K; Yamashina M; Okizaki A
Ann Nucl Med; 2020 Dec; 34(12):926-931. PubMed ID: 32955663
[TBL] [Abstract][Full Text] [Related]
44. [The role of bone scintigraphy and its value in the staging and follow up of prostatic carcinoma].
Adám E; Gervain M; Rajtár M; Oszlánczi J; Csernay L; Scultéty S
Orv Hetil; 1989 Feb; 130(7):335-40. PubMed ID: 2645558
[TBL] [Abstract][Full Text] [Related]
45. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact.
Hsu CC; Chen YW; Huang YF; Chuang YW
Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746
[TBL] [Abstract][Full Text] [Related]
46. Bone and Tl-201 scintigraphy in a case of hereditary multiple exostoses.
Tani A; Tsuchimochi S; Nakabeppu Y; Nakajo M
Clin Nucl Med; 2001 Dec; 26(12):1028-31. PubMed ID: 11711707
[TBL] [Abstract][Full Text] [Related]
47. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
Bathmann J; Moser E
Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
[TBL] [Abstract][Full Text] [Related]
48. Prostatic adenocarcinoma with osseous metastases in a dog.
Lee-Parritz DE; Lamb CR
J Am Vet Med Assoc; 1988 Jun; 192(11):1569-72. PubMed ID: 3045059
[TBL] [Abstract][Full Text] [Related]
49. [Incidental finding of bladder diverticulum in bone scintigraphy].
Barandela Salgado J; Nogueiras Alonso JM; Outomuro Pérez JM; Serena Puig A; Campos Villarino L
Rev Esp Med Nucl; 2003; 22(4):258-9. PubMed ID: 12846953
[No Abstract] [Full Text] [Related]
50. Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy.
Yang J; Zhen L; Zhuang H
Clin Nucl Med; 2013 Dec; 38(12):988-91. PubMed ID: 24152640
[TBL] [Abstract][Full Text] [Related]
51. [Clinical evaluation of 201Tl-chloride scintigraphy for bone lesions (author's transl)].
Shishido F; Tsuya A; Ko S; Tokumoto Y; Tateno Y; Uchida I; Kawaguchi T; Wada N; Matsumoto S; Umegaki Y
Kaku Igaku; 1981 May; 18(4):455-62. PubMed ID: 7289211
[No Abstract] [Full Text] [Related]
52. [A patient with multiple bone metastases from gastric cancer after an 8-year disease-free interval following gastrectomy].
Takemura M; Osugi H; Lee S; Nishikawa T; Fukuhara K; Iwasaki H
Gan To Kagaku Ryoho; 2005 Apr; 32(4):515-7. PubMed ID: 15853219
[TBL] [Abstract][Full Text] [Related]
53. [Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology].
Feggi LM; Spanedda R; Scutellari PN; Prandini N; Gennari M; Orzincolo C; Scapoli GL; Bagni B
Radiol Med; 1988 Oct; 76(4):311-5. PubMed ID: 3141987
[TBL] [Abstract][Full Text] [Related]
54. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
55. Clinical manifestations and diagnostic approach to metastatic cancer of the mandible.
Glaser C; Lang S; Pruckmayer M; Millesi W; Rasse M; Marosi C; Leitha T
Int J Oral Maxillofac Surg; 1997 Oct; 26(5):365-8. PubMed ID: 9327288
[TBL] [Abstract][Full Text] [Related]
56. Dynamic scintigraphy with thallium-201 chloride (Tl-201) for the diagnosis of tumors of the head and neck.
Sato T; Indo H; Kawabata Y; Iwashita Y; Morita Y; Noikura T; Sugihara K; Mimura T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):228-35. PubMed ID: 11505272
[TBL] [Abstract][Full Text] [Related]
57. Correlation between BMD and bone scintigraphy in patients with prostate cancer.
Perk H; Yildiz M; Kosar A; Cerci S; Soyupek F; Ozorak A; Dilmen C
Urol Oncol; 2008; 26(3):250-3. PubMed ID: 18452814
[TBL] [Abstract][Full Text] [Related]
58. Detection of melanoma metastases with thallium-201 scintigraphy.
Rettenbacher L; Koller J; Kässmann H; Galvan G
J Nucl Med; 1998 May; 39(5):798-802. PubMed ID: 9591578
[TBL] [Abstract][Full Text] [Related]
59. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
60. [Recent advances in isotopic exploration of the skeletal system in prostate cancer (author's transl)].
Oliveux A; Grob JC; Moyses B; Methlin G; Bollack C
Sem Hop; 1980 Feb 18-25; 56(7-8):346-50. PubMed ID: 6246630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
